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Prevalence of positive prick test to anaesthetic drugs in the surgical
population
Allergic reactions occurring during anaesthesia are al-
ways a concern for anaesthesiologists in all countries,
because of the clinical repercussions as well as the
medical–legal implications (1, 2). In Spain, in 1993, the
High Court found an anaesthesiologist guilty for failing
to carry out allergy tests on a patient who was about to
undergo surgical intervention under general anaesthetic,
and who subsequently suﬀered a serious allergic accident
(2). Since then, many anaesthesiologists have begun to
demand that allergy tests are performed for all substances
used in surgical interventions, resulting in the collapse of
allergy units. Allergy tests on anaesthetizing are indicated
only among those patients who have a history of an
adverse reaction to these; this is the case, in fact, with
other drugs (2, 3). However, no information is available
regarding prevalence of prick tests among the surgical
population without the criteria mentioned.
The aim of this study was to assess the prevalence of
positive prick tests to drugs used during anaesthesia in the
surgical population and to analyse the contribution of
risk factors in the presentation of positive prick tests to
anaesthetic drugs.
A prospective study from 1 September 2003 to 30 July
2004 of 424 patients (146, 34.4% males and 278, 65.6%
females) who attended consultation for preanaesthesia in
two Valladolid Hospitals was performed. The study was
approved by the Hospital Research Committee and the
patients gave their consent in writing. The selection of
patients was random. Every day, the ﬁrst two patients
over 18 years of age attending each of the two preanaes-
thesia consultations were asked if they would volunteer
for a prick test for anaesthetic agents. If they agreed,
patients were referred to the allergy unit for the prick test
of the 30 substances listed in Table 1.
In order to evaluate the possible interactions among the
independent variables, we carried out a logistic regression
analysis (spss 11.5, Chicago, IL, USA). Odds ratio (OR)
was established at 95% conﬁdence interval (CI). AP-value
of <0.05 were considered statistically signiﬁcant.
Twenty of the 424 (4.7%) patients had positive prick
tests to one of the agents analysed (Table 1), the largest
percentage being neuromuscular blocking drugs (2.8%).
After the application of logistical regression for analysing
risk factors (age, sex, history of atopy, history of allergic
reaction to drugs, history of general anaesthesia and family
allergy history), a history of allergy to drugs is the only
factor, which was seen to have a predisposing inﬂuence on
the presentation of a positive prick test to anaesthetic drugs
(OR ¼ 6.13, 95% CI: 2.25–16.76, P < 0.0001).
Unlike previous studies (4–6), this is the only study that
determined the prevalence of positive prick tests to
anaesthesia-related drugs in a random sample of the
surgical population. We found that 4.7% of patients in
our cohort had positive prick tests. These results weremore
frequent among patients with a prior history of allergy to
drugs.
There is some controversy concerning the use of prick
tests in anaesthesia (1, 3, 6) and the relevance of positive
prick tests as a result of prick determinations. There are
frequent cases of false-positive prick tests, positive prick
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tests support, but do not necessarily conﬁrm, the diag-
nosis of allergy, and there is an absence of clear
internationally accepted guidelines on skin prick testing,
especially in relation to threshold test concentrations.
These aspects should be taken into account when
evaluating the prevalence of a positive prick test.
This study shows that the prevalence of patients
with positive prick tests to anaesthetics occurred in
4.7% in this prospective cohort. Of the various factors
examined, only prior history of allergy to medications
was shown to predict positive prick tests to anaesthetic
drugs.
Table 1. Prevalence of patients with positive prick test and agents involved in the surgical population
Drug n ¼ 424 % 95% confidence interval Concentration of drug (mg/ml)
Hypnotics 2 0.5 0.44–1.12
Midazolam 0 0.0 1
Propofol 0 0.0 20
Etomidate 2 0.5 0.44–1.12 2
Thiopental 0 0.0 2.5
Diazepam 0 0.0 5
Ketamine 0 0.0 50
Opioids 0 0.0
Fentanyl 0 0.0 0.05
Remifentyl 0 0.0 0.0
Alfentanil 0 0.0 0.5
Morphine 0 0.0 10*
Neuromuscular blocking 12 2.8 1.25–4.41
Suxamethonium 8 1.9 0.59–3.18 50
Atracurium 2 0.5 0.44–1.12 10*
Vecuronium 0 0.0 1
Pancuronium 0 0.0 2
Rocuronium 2 0.5 0.44–1.12 10
Mivacurium 0 0.0 2*
Cisatracurium 0 0.0 2
Latex 2 0.5 0.44–1.12 0.5
Iodine 4 0.9 0.22–1.86 Dried 10% povidone-iodine solution
Local anaesthetics 0 0.0
Mepivacaine 0 0.0 20
Bupivacaine 0 0.0 5
Lidocaine 0 0.0 20
Ropivaca 0 0.0 2
Coadjuvants (others) 0 0.0
Atropine 0 0.0 1
Flumazenyl 0 0.0 0.1
Naloxone 0 0.0 0.4
Thalamonal 0 0.0 Droperidol 2.5 + fentanyl 0.05
Droperidol 0 0.0 2.5
Metoclopramide 0 0.0 5
Ranitidine 0 0.0 10
Total 20 4.7 3.68–8.40
*For atracurium, mivacurium and morphine, were tested using a 1 : 10 dilution of the commercially available drug.
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